Health Technology · Pharmaceuticals: Major · NSE: STAR · data 2026-10-09

Strides Pharma Science Ltd

Health check: Strong (8.4/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹1,085.3

Market cap

₹10,094 cr

P/E

16.3

P/B

—

ROE

19.7%

ROCE

15.1%

Debt / equity

0.57

Dividend yield

0.46%

1-year return

36.2%

52-week high

₹1,260.9

52-week low

₹768.65

Operating margin

14.5%

Growth

Revenue (last 12 months)	₹5,004 cr
Net profit (last 12 months)	₹614 cr
Sales growth, 3 years (yearly)	9.2%
Profit growth, 3 years (yearly)	—

Similar companies

Corona Remedies Limited (CORONA) · Viyash Scientific Limited (VIYASH) · Blue Jet Healthcare Limited (BLUEJET) · Procter & Gamble Health Ltd. (PGHL) · Sanofi Consumer Healthcare India Limited (SANOFICONR)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open STAR in NSE Scanner →